Embera NeuroTherapeutics, Inc.
BioSpace1, 2031 Kings Highway
Shreveport, LA 71103
BioSpace1, 2031 Kings Highway
Shreveport, LA 71103
Embera Team
- Robert B. Linke
- Bruce McCarthy, MD
- Nicholas Goeders, Ph.D.
- Carol A. Gloff, Ph.D.
- Ross P. Barrett
- Franz Hefti, Ph.D.
- Joseph F. Lovett
Scientific Advisory Board
Investors
Robert B. Linke - President and Chief Executive Officer
Mr. Linke has over twenty-four years of diversified healthcare experience in pharma/biopharmaceutical, medical device, diagnostic, and healthcare informatics markets. His healthcare experience includes leadership roles at both public and private equity-backed companies, which include Periodontix, a biotech company, and Rapid Micro Biosystems, a diagnostic company.
Bruce McCarthy, MD - Chief Medical Officer and Vice President of Clinical Development
Dr. McCarthy is an experienced neurologist and leading expert in neuroscience drug development. At Pfizer, he was responsible for neuroscience development and clinicians in his organization obtained approval for Chantix®. He was also the Global Project Head/Venture Head at Abbott, where he led their neuroscience teams.
Nicholas E. Goeders, PhD. - Chief Scientific Officer, Director.
Dr. Goeders is a founder of the Company and internationally recognized leader in addiction research. He is currently the Head of the Department of Pharmacology, Toxicology & Neuroscience at the Louisiana State University Health Sciences Center in Shreveport, Louisiana.
Carol Gloff, Ph.D. – Regulatory Consultant
Dr. Gloff is an experienced regulatory consultant and former VP of Regulatory Affairs for Alkermes and ImmunoGen, who is providing regulatory guidance and assistance to the Company in preparing and submitting its first IND.